Missed rifampicin and isoniazid resistance by commercial molecular assays
Drug-resistant tuberculosis (TB) has poor outcomes unless resistance is detected early, ideally by commercially available molecular tests. We present a case of occult multidrug-resistant TB where both rifampicin and isoniazid resistance were missed by molecular testing and were only identified...
| الحاوية / القاعدة: | South African Medical Journal |
|---|---|
| المؤلفون الرئيسيون: | , , , |
| التنسيق: | مقال |
| اللغة: | الإنجليزية |
| منشور في: |
South African Medical Association
2024-07-01
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://samajournals.co.za/index.php/samj/article/view/1779 |